Advertisement
U.S. markets closed

WaveDancer, Inc. (WAVD)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
3.4600-0.1400 (-3.89%)
At close: 04:00PM EDT
3.4000 -0.06 (-1.73%)
After hours: 06:14PM EDT
Full screen
Loading interactive chart...
  • GlobeNewswire

    WaveDancer and Firefly Neuroscience, an AI-Driven Brain Health Company, Each Receive Respective Stockholder Approvals for Merger

    Successful votes from both parties’ stockholders mark a critical step toward deal closing with the pioneering artificial intelligence-enabled neurological technology company.FAIRFAX, Va., March 18, 2024 (GLOBE NEWSWIRE) -- WaveDancer, Inc. (“WaveDancer”) (Nasdaq: WAVD) and Firefly Neuroscience, Inc. (“Firefly”) an AI-driven brain health company, each received the requisite stockholder approvals required to consummate the merger between both companies. The WaveDancer stockholder approval was obta

  • GlobeNewswire

    WaveDancer Encourages Stockholders to Vote FOR the Proposals in Advance of the March 14, 2024 Special Meeting

    Most stockholders can vote via proxyvote.com or by calling 1-800-690-6903. FAIRFAX, Va., March 11, 2024 (GLOBE NEWSWIRE) -- WaveDancer, Inc. (Nasdaq: WAVD) encourages its stockholders to participate actively by casting their vote now for the upcoming meeting of stockholders on March 14, 2024. The Board of Directors emphasizes the importance of this stockholders' vote, specifically urging a positive vote FOR each proposal contained in the proxy, a copy of which can be found at https://ir.wavedanc

  • GlobeNewswire

    Firefly Neuroscience’s White Paper Unveils BNA™ Platform’s Significant Impact on Disease Management in 2,253 U.S Patients

    The white paper is titled “Brain Network Analytics (BNA) in the Psychiatric Practice: Real-Life Data Analysis” The analysis involved a cohort of 2,253 patients receiving treatment at a prominent psychiatric and multispecialty clinic in the U.S. FAIRFAX, Va. and TORONTO, March 05, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly”), a pioneering AI company developing innovative neuroscientific solutions to improve outcomes for patients with mental illnesses and neurological disorders,